Replimune Group, Inc.
REPL
$5.67
$0.071.25%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 32.80M | 25.57M | 18.21M | 15.70M | 14.62M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 90.00M | 78.78M | 65.64M | 58.51M | 56.93M |
Operating Income | -90.00M | -78.78M | -65.64M | -58.51M | -56.93M |
Income Before Tax | -86.69M | -74.24M | -65.77M | -53.06M | -53.77M |
Income Tax Expenses | -- | -107.00K | 575.00K | -- | -- |
Earnings from Continuing Operations | -86.69M | -74.13M | -66.34M | -53.06M | -53.77M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -86.69M | -74.13M | -66.34M | -53.06M | -53.77M |
EBIT | -90.00M | -78.78M | -65.64M | -58.51M | -56.93M |
EBITDA | -89.43M | -75.10M | -64.95M | -57.68M | -56.19M |
EPS Basic | -0.95 | -0.82 | -0.79 | -0.78 | -0.79 |
Normalized Basic EPS | -0.59 | -0.51 | -0.49 | -0.48 | -0.49 |
EPS Diluted | -0.95 | -0.82 | -0.79 | -0.78 | -0.79 |
Normalized Diluted EPS | -0.59 | -0.51 | -0.49 | -0.48 | -0.49 |
Average Basic Shares Outstanding | 91.52M | 90.92M | 83.50M | 68.39M | 68.31M |
Average Diluted Shares Outstanding | 91.52M | 90.92M | 83.50M | 68.39M | 68.31M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |